Search results
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoThat compares to 55.6% for Keytruda alone. Earlier in the year, one analyst called results from the...
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
Morningstar· 1 day agoManufacturing is underway and doses of Moderna's Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval CAMBRIDGE, MA / ACCESSWIRE ...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 3 days agoThe conversation with your doctor should include whether the vaccine is appropriate for you, and if...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 6 days agoModerna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented ...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 3 days agoThey are also safe and effective at preventing the development of specific infections. However, the...
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
CNBC· 1 day agoThe Food and Drug Administration on Friday expanded the approval of GSK's respiratory syncytial...
The chicken and egg problem of fighting another flu pandemic
Oregon Capital Chronicle via Yahoo News· 12 hours agoEven a peep of news about a new flu pandemic is enough to set scientists clucking about eggs. They...
First human death in Mexico from H5N2 influenza strain adds to bird flu anxiety
The Telegraph via Yahoo News· 2 days agoScientists are scrambling to understand the rapidly evolving bird flu situation in North America, as...
How Messenger RNA Made The COVID Vaccines Possible
Science Friday· 2 days agoThe following is an excerpt from The Catalyst: RNA and the Quest to Unlock Life’s Deepest Secrets by Thomas R. Cech. On January 10, 2020, Prof. Yong-Zhen Zhang of Fudan University in Shanghai ...